BrainStorm Cell Therapeutics
BCLI
#10526
Rank
A$11.27 M
Marketcap
A$1.02
Share price
-6.49%
Change (1 day)
-45.58%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -A$16.97 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$16.49 Million, an increase over its 2023 earnings that were of -A$24.39 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$16.97 Million2.91%
2024 -A$16.49 Million-32.39%
2023 -A$24.39 Million-29.18%
2022 -A$34.44 Million-0.74%
2021 -A$34.7 Million-23.12%
2020 -A$45.13 Million36.8%
2019 -A$32.99 Million66.71%
2018 -A$19.79 Million181.66%
2017 -A$7.03 Million-0.6%
2016 -A$7.07 Million-41.31%
2015 -A$12.05 Million-8.22%
2014 -A$13.12 Million89.74%
2013 -A$6.92 Million42.27%
2012 -A$4.86 Million-12.45%
2011 -A$5.56 Million63.04%
2010 -A$3.41 Million35.52%
2009 -A$2.52 Million-48.99%
2008 -A$4.93 Million-44.39%
2007 -A$8.86 Million
2005 -A$4.59 Million-91.44%
2004 -A$53.6 Million94007.62%
2003 -A$0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
A$2.30 B-15,064.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$13.89 B-90,428.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-A$1.13 Billion 7,189.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-A$1.18 Billion 7,549.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$29.31 M-290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-A$0.37 Billion 2,255.61%๐Ÿ‡บ๐Ÿ‡ธ USA